Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grupos

Publicaciones

  • MATIASGUIU, X; Pons, C; Prat, J

    Alpha-inhibin, mullerian inhibiting substance and CD 99 expression in functioning ovarian tumors.

    LABORATORY INVESTIGATION 76 607-607. .

  • MATIASGUIU, X; Garcia, A; Cabezas, R; Chico, A; Baiget, M; DeLeiva, A; Prat, J

    Molecular diagnosis of VonHippel-Lindau disease in familial pheochromocytoma

    LABORATORY INVESTIGATION 76 280-280. .

  • MATIASGUIU, X; Lagarda, E; Calaf, M; Azpiroz, A; DeLeiva, A; Prat, J; Baiget, M

    Identification of a novel somatic mutation in the RET proto oncogene in a patient with sporadic medullary thyroid carcinoma

    HUM MUTAT 9 476-476. .

    [doi:10.1002/(SICI)1098-1004(1997)9:5<476::AID-HUMU20>3.0.CO;2-Z]

  • MATIASGUIU, X; Villanueva, A; Cuatrecasas, M; Capella, G; DeLeiva, A; Prat, J

    p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma

    PATHOL RES PRACT 192 1242-1249. .

  • Fornas, O; Mato, ME; Viader, M; Oliver, B; Tresserres, P; Bartumeus, F; Tugues, D; Petriz, J; MATIASGUIU, X; Webb, SM

    Flow cytometry analysis of pituitary adenomas

    Hormone Research 46 257-262. .

    [doi:10.1159/000185097]

  • Biarnes, J; Miranda, M; Corral, J; Gabau, E; MATIASGUIU, X; Matilla, A; Soler, J; Estivill, X; Volpini, V

    The molecular pathology of RET protooncogen in families with multiple endocrine neoplasm type 2a

    MEDICINA CLINICA 107 321-325. .

  • Domingo, P; Rodriguez, P; LopezContreras, J; Rebasa, P; Mota, S; MATIASGUIU, X

    Spontaneous rupture of the spleen associated with pneumonia

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 15 733-736. .

    [doi:10.1007/BF01691960]

  • Cuatrecasas, M; MATIASGUIU, X; Prat, J

    Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei - a clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 20 739-746. .

    [doi:10.1097/00000478-199606000-00012]

  • Berna, L; Caixas, A; Piera, J; Gomez, G; MATIASGUIU, X; Estorch, M; Puig, M; Carrio, I

    Technetium-99m-methoxyisobutylisonitrile in Localization of ectopic parathyroid adenoma

    Journal Of Nuclear Medicine 37 631-633. .

  • Capella, G; MATIASGUIU, X; Ampudia, X; deLeiva, A; Perucho, M; Prat, J

    Ras oncogene mutations in thyroid tumors - Polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues

    Diagnostic Molecular Pathology 5 45-52. .

    [doi:10.1097/00019606-199603000-00008]

  • Chico, A; Pallares, MC; MATIASGUIU, X; Cipres, L; PuigDomingo, M; Webb, SM

    Bronchial carcinoid tumor presenting as a thyroid nodule: an unusual clinical manifestation

    Journal Of Endocrinological Investigation 19 186-189. .

  • Sole, JM; Guedea, F; MATIASGUIU, X; Lerma, E; Seral, A

    Long-term risk of sarcoma following radiation treatment for breast cancer

    ONCOL REP 3 397-399. .

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU